Evaluate the efficacy of Kaishora Guggulu with and withoutVirechana Karma in the management of Vatarakta (Gout)
Phase 2
Completed
- Conditions
- Health Condition 1: E799- Disorder of purine and pyrimidinemetabolism, unspecifiedHealth Condition 2: M109- Gout, unspecified
- Registration Number
- CTRI/2021/03/032128
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Subjects presenting with clinical features of
Vatarakta.
2. Subjects with chronicity of disease more than
6 months and less than 5 years
3. Subjects showing the uric acid level more
th� n 7 mg/dl.
4. Subjects fit for Virechana Karma.
Exclusion Criteria
1. Subjects with uncontrolled metabolic
disorder and other systemic disorders.
2. Subjects prediagnosed with autoimmune
disease of joints.
3. Subject with infection and communicable
diseases.
4. Subject not fit for Virechana Karma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in pain and reduction in serum uric acid level. <br/ ><br>Timepoint: 1st day,60th day,84th day
- Secondary Outcome Measures
Name Time Method 1. Reduction in other symptoms like Sandhigraha, Twak Vaivarnya. <br/ ><br>2. Overall improvement in quality of life. <br/ ><br>3. Reduction in level of elevated ESRTimepoint: 0th days, 60th day,84th day